推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 CANCER BIOTHER 最新评论:网站进不去? (2023-11-29)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS期刊基本信息Hello,您是该期刊的第33025位访客


基本信息 登录收藏
期刊名字CANCER BIOTHERAPY AND RADIOPHARMACEUTICALSCANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

CANCER BIOTHER RADIO
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
5.3
51人评分
我要评分

声誉
6.3

影响力
3.8

速度
8.6

期刊ISSN1084-9785
微信扫码收藏此期刊
E-ISSN1557-8852
2023-2024最新影响因子
(数据来源于搜索引擎)
2.4 点击查看影响因子趋势图
实时影响因子 截止2024年10月29日:1.689
2023-2024自引率0.00%点击查看自引率趋势图
五年影响因子2.6
JCI期刊引文指标 0.76
h-index 55
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
7.800.6070.555
学科分区排名百分位
大类:Medicine
小类:Radiology, Nuclear Medicine and Imaging
Q137 / 333
大类:Medicine
小类:Oncology
Q183 / 404
大类:Medicine
小类:Pharmacology
Q175 / 313
大类:Medicine
小类:Cancer Research
Q274 / 230

期刊简介
Cancer Biotherapy and Radiopharmaceuticals is the established peer-reviewed journal, with over 25 years of cutting-edge content on innovative therapeutic investigations to ultimately improve cancer management. It is the only journal with the specific focus of cancer biotherapy and is inclusive of monoclonal antibodies, cytokine therapy, cancer gene therapy, cell-based therapies, and other forms of immunotherapies.

The Journal includes extensive reporting on advancements in radioimmunotherapy, and the use of radiopharmaceuticals and radiolabeled peptides for the development of new cancer treatments.
期刊官方网站http://www.liebertpub.com/overview/cancer-biotherapy-and-radiopharmaceuticals/8/
期刊投稿网址http://mc.manuscriptcentral.com/Cancerbiotherapy
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS的语言要求,还能让CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801
出版商Mary Ann Liebert Inc.
涉及的研究方向医学-核医学
出版国家或地区UNITED STATES
出版语言English
出版周期Bimonthly
出版年份1996
年文章数 27点击查看年文章数趋势图
Gold OA文章占比5.17%
研究类文章占比:
文章 ÷(文章 + 综述)
92.59%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:2区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:MEDICINE, RESEARCH & EXPERIMENTALSCIEQ3105/189
学科:ONCOLOGYSCIEQ3193/322
学科:PHARMACOLOGY & PHARMACYSCIEQ3188/354
学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGINGSCIEQ278/204
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:MEDICINE, RESEARCH & EXPERIMENTALSCIEQ274/189
学科:ONCOLOGYSCIEQ2128/322
学科:PHARMACOLOGY & PHARMACYSCIEQ2136/354
学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGINGSCIEQ279/204
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 4区4区3区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
1区3区4区
ONCOLOGY
肿瘤学
4区1区4区
PHARMACOLOGY & PHARMACY
药学
4区3区4区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
核医学
1区3区4区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 4区4区3区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
2区2区4区
ONCOLOGY
肿瘤学
4区3区4区
PHARMACOLOGY & PHARMACY
药学
1区2区4区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
核医学
4区4区4区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 3区4区3区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
3区4区4区
ONCOLOGY
肿瘤学
4区3区4区
PHARMACOLOGY & PHARMACY
药学
3区3区4区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
核医学
1区2区4区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1084-9785%5BISSN%5D
平均审稿速度网友分享经验:
平均3月
平均录用比例网友分享经验:
约95%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    RADIOLOGY27135.20
    Radiologia Medica4114.10
    CLINICAL NUCLEAR MEDICINE532.90
    JOURNAL OF NUCLEAR MEDICINE19513.00
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING15315.60
    INVESTIGATIVE RADIOLOGY10315.10
    Circulation-Cardiovascular Imaging836.30
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS22811.00
    COMPUTERIZED MEDICAL IMAGING AND GRAPHICS6310.70
    RADIOGRAPHICS1518.20
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE673064
    BIOMATERIALS564108
    BIOMEDICINE & PHARMACOTHERAPY548122
    Frontiers in Pharmacology512053
    Journal of Materials Chemistry B501778
    Frontiers in Immunology488366
    COMPUTERS IN BIOLOGY AND MEDICINE469163
    JOURNAL OF ETHNOPHARMACOLOGY462920
    COLLOIDS AND SURFACES B-BIOINTERFACES436753
    Frontiers in Oncology433549
  •  

    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Long Noncoding RNA Regulator of Reprogramming Regulates Cell Growth, Metastasis, and Cisplatin Resistance in Gastric Cancer via miR-519d-3p/HMGA2 Axis

    Author: Jin, Wenhua; Zhang, Hua; Li, Meng; Lin, Sen
    Journal: CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 2023; Vol. 38, Issue 2, pp. 122-131. DOI: 10.1089/cbr.2019.3525
        PubMed      DOI
    2.LncRNA IUR Is Downregulated in Gastric Carcinoma and Associated with Poor Survival

    Author: Ou, Rui; Liu, Xin
    Journal: CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 2023; Vol. 38, Issue 2, pp. 116-121. DOI: 10.1089/cbr.2019.3436
        PubMed      DOI
    3.Gene Silencing of Transcription Factor TEAD4 Inhibits Esophageal Cancer Cells by Regulating TCF7

    Author: He, Songlin; Gao, Ke; Mao, Long; Bhushan, Sandeep; Xiao, Zongwei
    Journal: CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 2023; Vol. 38, Issue 2, pp. 132-139. DOI: 10.1089/cbr.2020.3870
        PubMed      DOI
    4.Survival Advantages in Gastric Cancer Patients Receiving Preoperative SOX Regimen Chemotherapy

    Author: Zhang, Qian; Zhang, Qinghua; Yan, Hui; You, Yanjie; Cao, Juan; Wang, Wenfan; Zhao, Dan; Zhang, Xiaoxu; Wu, Jing; Chen, Zhiqiang; Yang, Wenjun
    Journal: CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 2023; Vol. 38, Issue 2, pp. 81-88. DOI: 10.1089/cbr.2020.3970
        PubMed      DOI
    5.Effect of Oral Nutritional Supplements on Patients with Esophageal Cancer During Radiotherapy

    Author: Yang, Liping; Gao, Jing; Zhou, Yan; Tao, Zhenchao; He, Jian; Yang, Jing; Wang, Ru; Zhang, Yangyang; Huang, Yifan; Zhou, Lingran; Sun, Bin
    Journal: CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 2023; Vol. 38, Issue 2, pp. 89-94. DOI: 10.1089/cbr.2020.3888
        PubMed      DOI
    6.Circ_0003789 Facilitates Gastric Cancer Progression by Inducing the Epithelial-Mesenchymal Transition through the Wnt/beta-Catenin Signaling Pathway

    Author: Shao, Zhongbao; Yuan, Chang; Hu, Junbao; Wu, Yuli; Zeng, Chong
    Journal: CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 2023; Vol. 38, Issue 2, pp. 102-110. DOI: 10.1089/cbr.2020.4044
        PubMed      DOI
    7.Diagnostic and Prognostic Value of Serum miR-296-5p and miR-28-3p in Human Gastric Cancer

    Author: Guo, Yuntong; Cui, Xiaolong; Zhang, Yu; Ma, Xiaobo; Ren, Aigang; Huang, He
    Journal: CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 2023; Vol. 38, Issue 2, pp. 95-101. DOI: 10.1089/cbr.2020.4144
        PubMed      DOI
    8.Effects of Citrus aurantium L. on Gastrointestinal Motility and Gastric Cancer Cell Proliferation

    Author: Gao, Meng; Yang, Wuliang
    Journal: CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 2023; Vol. 38, Issue 2, pp. 111-115. DOI: 10.1089/cbr.2020.4267
        PubMed      DOI
    9.Exosome-Mediated Transfer of circ-GLIS3 Enhances Temozolomide Resistance in Glioma Cells Through the miR-548m/MED31 Axis

    Author: Li, Guowei; Lan, Qing
    Journal: CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 2023; Vol. 38, Issue 1, pp. 62-73. DOI: 10.1089/cbr.2021.0299
        PubMed      DOI
    10.A Novel Prognostic Biomarker CCR8 for Gastric Cancer and Anti-CCR8 Blockade Attenuate the Immunosuppressive Capacity of Tregs In Vitro

    Author: Zhang, Zhigang; Wang, Guoqing; Shao, Xiangyu; Wu, Hailu; Su, Xiangyu; Zhu, Long; Ji, Zhenling
    Journal: CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS. 2023; Vol. , Issue , pp. -. DOI: 10.1089/cbr.2022.0095
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Energy Material Advances013.80
    Journal of High Energy Astrophysics119.70
    VIEW012.60
    HARVARD BUSINESS REVIEW01.40
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE1086.90
    ACM Transactions on Intelligent Systems and Technology469.30
    Journal of the American Nutrition Association02.50
    TRANSACTIONS OF TIANJIN UNIVERSITY012.50
    Machine Intelligence Research06.70
    Molecular Biomedicine06.30
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共58


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室